Search

Your search keyword '"Eliasson, Björn"' showing total 1,054 results

Search Constraints

Start Over You searched for: Author "Eliasson, Björn" Remove constraint Author: "Eliasson, Björn"
1,054 results on '"Eliasson, Björn"'

Search Results

151. sj-docx-1-vmj-10.1177_1358863X211008249 – Supplemental material for Diabetes mellitus was not associated with lower amputation-free survival after open revascularization for chronic limb-threatening ischemia – A nationwide propensity score adjusted analysis

152. Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes : 12 months prospective randomized trial

153. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden : A nationwide retrospective cohort study

154. Use of incretin-based drugs and risk of cholangiocarcinoma:Scandinavian cohort study

155. Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes:the PROLONG study

156. Association of Gastric Bypass Surgery With Risk of Developing Diabetic Retinopathy Among Patients With Obesity and Type 2 Diabetes in Sweden : An Observational Study

158. Higher long-term cardiovascular morbidity after open surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes – a nationwide observational cohort study

159. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

160. Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial

164. Additional file 1 of Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up

165. Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

166. sj-docx-2-tae-10.1177_2042018820960294.docx – Supplemental material for Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes

167. sj-docx-3-tae-10.1177_2042018820960294.docx – Supplemental material for Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes

169. sj-docx-1-tae-10.1177_2042018820960294.docx – Supplemental material for Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes

170. Statin dose titration patterns and subsequent major cardiovascular events in very high-risk patients : estimates from Swedish population-based registry data

171. Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms

172. Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes

173. Organisation of primary diabetes care in people with type 2 diabetes in relation to all-cause mortality : A nationwide register-based cohort study

174. Use of glucagon-like peptide 1 receptor agonists and risk of serious renal events:Scandinavian cohort study

175. Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events:Scandinavian cohort study

176. Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes : A Nationwide, Matched, Observational Cohort Study

177. Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes : Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits

180. Severe COVID-19 in People with Type 1 and Type 2 Diabetes in Sweden: A Nationwide Retrospective Case-Control Study

183. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

184. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study.

185. The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study.

188. Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms

191. Organisation of primary diabetes care in people with type 2 diabetes in relation to all-cause mortality: A nationwide register-based cohort study

193. Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes

196. Adipose tissue morphology, imaging and metabolomics predicting cardiometabolic risk and family history of type 2 diabetes in non-obese men

198. Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

Catalog

Books, media, physical & digital resources